The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Polymyxins market was valued at US$ 2807.6 million in 2023 and is anticipated to reach US$ 3654.5 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
Rising Antibiotic Resistance: The emergence of antibiotic-resistant bacteria, including multidrug-resistant Gram-negative pathogens like carbapenem-resistant Enterobacteriaceae (CRE) and Pseudomonas aeruginosa, has increased the use of polymyxins as last-resort treatments.
Limited Treatment Options: Polymyxins are considered one of the few remaining treatment options for infections caused by extensively drug-resistant (XDR) and pandrug-resistant (PDR) Gram-negative bacteria. Their use is often reserved for cases where no other antibiotics are effective.
This report aims to provide a comprehensive presentation of the global market for Polymyxins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymyxins.
Report Scope
The Polymyxins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymyxins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymyxins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Meiji Seika Pharm
Shengxue Dacheng
Apeloa
Livzon Group
LKPC
Xellia
BIOK
Vetbiochem
Qianjiang Biochemical
VEGA
Huazhong Pharmaceutical
Segment by Type
Injection Polymyxins
External Polymyxins
Segment by Application
Intestinal Disease
Infection
Septicemia
Peritonitis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polymyxins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polymyxins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Polymyxins market was valued at US$ 2807.6 million in 2023 and is anticipated to reach US$ 3654.5 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
Rising Antibiotic Resistance: The emergence of antibiotic-resistant bacteria, including multidrug-resistant Gram-negative pathogens like carbapenem-resistant Enterobacteriaceae (CRE) and Pseudomonas aeruginosa, has increased the use of polymyxins as last-resort treatments.
Limited Treatment Options: Polymyxins are considered one of the few remaining treatment options for infections caused by extensively drug-resistant (XDR) and pandrug-resistant (PDR) Gram-negative bacteria. Their use is often reserved for cases where no other antibiotics are effective.
This report aims to provide a comprehensive presentation of the global market for Polymyxins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymyxins.
Report Scope
The Polymyxins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymyxins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymyxins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Meiji Seika Pharm
Shengxue Dacheng
Apeloa
Livzon Group
LKPC
Xellia
BIOK
Vetbiochem
Qianjiang Biochemical
VEGA
Huazhong Pharmaceutical
Segment by Type
Injection Polymyxins
External Polymyxins
Segment by Application
Intestinal Disease
Infection
Septicemia
Peritonitis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polymyxins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polymyxins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Polymyxins Market Overview
1.1 Product Overview and Scope of Polymyxins
1.2 Polymyxins Segment by Type
1.2.1 Global Polymyxins Market Value Comparison by Type (2024-2030)
1.2.2 Injection Polymyxins
1.2.3 External Polymyxins
1.3 Polymyxins Segment by Application
1.3.1 Global Polymyxins Market Value by Application: (2024-2030)
1.3.2 Intestinal Disease
1.3.3 Infection
1.3.4 Septicemia
1.3.5 Peritonitis
1.4 Global Polymyxins Market Size Estimates and Forecasts
1.4.1 Global Polymyxins Revenue 2019-2030
1.4.2 Global Polymyxins Sales 2019-2030
1.4.3 Global Polymyxins Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Polymyxins Market Competition by Manufacturers
2.1 Global Polymyxins Sales Market Share by Manufacturers (2019-2024)
2.2 Global Polymyxins Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Polymyxins Average Price by Manufacturers (2019-2024)
2.4 Global Polymyxins Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polymyxins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polymyxins, Product Type & Application
2.7 Polymyxins Market Competitive Situation and Trends
2.7.1 Polymyxins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Polymyxins Players Market Share by Revenue
2.7.3 Global Polymyxins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polymyxins Retrospective Market Scenario by Region
3.1 Global Polymyxins Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Polymyxins Global Polymyxins Sales by Region: 2019-2030
3.2.1 Global Polymyxins Sales by Region: 2019-2024
3.2.2 Global Polymyxins Sales by Region: 2025-2030
3.3 Global Polymyxins Global Polymyxins Revenue by Region: 2019-2030
3.3.1 Global Polymyxins Revenue by Region: 2019-2024
3.3.2 Global Polymyxins Revenue by Region: 2025-2030
3.4 North America Polymyxins Market Facts & Figures by Country
3.4.1 North America Polymyxins Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Polymyxins Sales by Country (2019-2030)
3.4.3 North America Polymyxins Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Polymyxins Market Facts & Figures by Country
3.5.1 Europe Polymyxins Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Polymyxins Sales by Country (2019-2030)
3.5.3 Europe Polymyxins Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polymyxins Market Facts & Figures by Country
3.6.1 Asia Pacific Polymyxins Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Polymyxins Sales by Country (2019-2030)
3.6.3 Asia Pacific Polymyxins Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Polymyxins Market Facts & Figures by Country
3.7.1 Latin America Polymyxins Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Polymyxins Sales by Country (2019-2030)
3.7.3 Latin America Polymyxins Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Polymyxins Market Facts & Figures by Country
3.8.1 Middle East and Africa Polymyxins Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Polymyxins Sales by Country (2019-2030)
3.8.3 Middle East and Africa Polymyxins Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polymyxins Sales by Type (2019-2030)
4.1.1 Global Polymyxins Sales by Type (2019-2024)
4.1.2 Global Polymyxins Sales by Type (2025-2030)
4.1.3 Global Polymyxins Sales Market Share by Type (2019-2030)
4.2 Global Polymyxins Revenue by Type (2019-2030)
4.2.1 Global Polymyxins Revenue by Type (2019-2024)
4.2.2 Global Polymyxins Revenue by Type (2025-2030)
4.2.3 Global Polymyxins Revenue Market Share by Type (2019-2030)
4.3 Global Polymyxins Price by Type (2019-2030)
5 Segment by Application
5.1 Global Polymyxins Sales by Application (2019-2030)
5.1.1 Global Polymyxins Sales by Application (2019-2024)
5.1.2 Global Polymyxins Sales by Application (2025-2030)
5.1.3 Global Polymyxins Sales Market Share by Application (2019-2030)
5.2 Global Polymyxins Revenue by Application (2019-2030)
5.2.1 Global Polymyxins Revenue by Application (2019-2024)
5.2.2 Global Polymyxins Revenue by Application (2025-2030)
5.2.3 Global Polymyxins Revenue Market Share by Application (2019-2030)
5.3 Global Polymyxins Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Meiji Seika Pharm
6.1.1 Meiji Seika Pharm Corporation Information
6.1.2 Meiji Seika Pharm Description and Business Overview
6.1.3 Meiji Seika Pharm Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Meiji Seika Pharm Polymyxins Product Portfolio
6.1.5 Meiji Seika Pharm Recent Developments/Updates
6.2 Shengxue Dacheng
6.2.1 Shengxue Dacheng Corporation Information
6.2.2 Shengxue Dacheng Description and Business Overview
6.2.3 Shengxue Dacheng Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shengxue Dacheng Polymyxins Product Portfolio
6.2.5 Shengxue Dacheng Recent Developments/Updates
6.3 Apeloa
6.3.1 Apeloa Corporation Information
6.3.2 Apeloa Description and Business Overview
6.3.3 Apeloa Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Apeloa Polymyxins Product Portfolio
6.3.5 Apeloa Recent Developments/Updates
6.4 Livzon Group
6.4.1 Livzon Group Corporation Information
6.4.2 Livzon Group Description and Business Overview
6.4.3 Livzon Group Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Livzon Group Polymyxins Product Portfolio
6.4.5 Livzon Group Recent Developments/Updates
6.5 LKPC
6.5.1 LKPC Corporation Information
6.5.2 LKPC Description and Business Overview
6.5.3 LKPC Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.5.4 LKPC Polymyxins Product Portfolio
6.5.5 LKPC Recent Developments/Updates
6.6 Xellia
6.6.1 Xellia Corporation Information
6.6.2 Xellia Description and Business Overview
6.6.3 Xellia Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Xellia Polymyxins Product Portfolio
6.6.5 Xellia Recent Developments/Updates
6.7 BIOK
6.6.1 BIOK Corporation Information
6.6.2 BIOK Description and Business Overview
6.6.3 BIOK Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BIOK Polymyxins Product Portfolio
6.7.5 BIOK Recent Developments/Updates
6.8 Vetbiochem
6.8.1 Vetbiochem Corporation Information
6.8.2 Vetbiochem Description and Business Overview
6.8.3 Vetbiochem Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vetbiochem Polymyxins Product Portfolio
6.8.5 Vetbiochem Recent Developments/Updates
6.9 Qianjiang Biochemical
6.9.1 Qianjiang Biochemical Corporation Information
6.9.2 Qianjiang Biochemical Description and Business Overview
6.9.3 Qianjiang Biochemical Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qianjiang Biochemical Polymyxins Product Portfolio
6.9.5 Qianjiang Biochemical Recent Developments/Updates
6.10 VEGA
6.10.1 VEGA Corporation Information
6.10.2 VEGA Description and Business Overview
6.10.3 VEGA Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.10.4 VEGA Polymyxins Product Portfolio
6.10.5 VEGA Recent Developments/Updates
6.11 Huazhong Pharmaceutical
6.11.1 Huazhong Pharmaceutical Corporation Information
6.11.2 Huazhong Pharmaceutical Polymyxins Description and Business Overview
6.11.3 Huazhong Pharmaceutical Polymyxins Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huazhong Pharmaceutical Polymyxins Product Portfolio
6.11.5 Huazhong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polymyxins Industry Chain Analysis
7.2 Polymyxins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polymyxins Production Mode & Process
7.4 Polymyxins Sales and Marketing
7.4.1 Polymyxins Sales Channels
7.4.2 Polymyxins Distributors
7.5 Polymyxins Customers
8 Polymyxins Market Dynamics
8.1 Polymyxins Industry Trends
8.2 Polymyxins Market Drivers
8.3 Polymyxins Market Challenges
8.4 Polymyxins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
